Next Article in Journal
Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus
Next Article in Special Issue
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
Previous Article in Journal / Special Issue
Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication
Review

Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, 77555 TX, USA
*
Author to whom correspondence should be addressed.
Viruses 2019, 11(1), 74; https://doi.org/10.3390/v11010074
Received: 18 December 2018 / Revised: 10 January 2019 / Accepted: 12 January 2019 / Published: 17 January 2019
(This article belongs to the Special Issue MERS-CoV)
Efforts towards developing a vaccine for Middle East respiratory syndrome coronavirus (MERS-CoV) have yielded promising results. Utilizing a variety of platforms, several vaccine approaches have shown efficacy in animal models and begun to enter clinical trials. In this review, we summarize the current progress towards a MERS-CoV vaccine and highlight potential roadblocks identified from previous attempts to generate coronavirus vaccines. View Full-Text
Keywords: Middle East respiratory syndrome coronavirus; severe acute respiratory syndrome coronavirus; coronavirus spike glycoprotein; vaccine platforms; correlates of immunity; animal models Middle East respiratory syndrome coronavirus; severe acute respiratory syndrome coronavirus; coronavirus spike glycoprotein; vaccine platforms; correlates of immunity; animal models
Show Figures

Figure 1

MDPI and ACS Style

Schindewolf, C.; Menachery, V.D. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses 2019, 11, 74. https://doi.org/10.3390/v11010074

AMA Style

Schindewolf C, Menachery VD. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses. 2019; 11(1):74. https://doi.org/10.3390/v11010074

Chicago/Turabian Style

Schindewolf, Craig, and Vineet D. Menachery 2019. "Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism" Viruses 11, no. 1: 74. https://doi.org/10.3390/v11010074

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop